DK1091966T3 - Selektive inhibitorer af det N-terminale sæde af ACE - Google Patents

Selektive inhibitorer af det N-terminale sæde af ACE

Info

Publication number
DK1091966T3
DK1091966T3 DK99926580T DK99926580T DK1091966T3 DK 1091966 T3 DK1091966 T3 DK 1091966T3 DK 99926580 T DK99926580 T DK 99926580T DK 99926580 T DK99926580 T DK 99926580T DK 1091966 T3 DK1091966 T3 DK 1091966T3
Authority
DK
Denmark
Prior art keywords
selective inhibitors
ace
po2ch2
amino acid
terminal seat
Prior art date
Application number
DK99926580T
Other languages
English (en)
Inventor
Vincent Dive
Philippe Cuniasse
Athanasios Yiotakis
Pierre Corvol
Annie Michaud
Marie-Therese Chauvet
Eric Ezan
Joel Cotton
Joel Menard
Original Assignee
Commissariat Energie Atomique
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Inst Nat Sante Rech Med filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of DK1091966T3 publication Critical patent/DK1091966T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99926580T 1998-07-02 1999-07-01 Selektive inhibitorer af det N-terminale sæde af ACE DK1091966T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9808464A FR2781230B1 (fr) 1998-07-02 1998-07-02 Derives de peptides utilisables comme inhibiteur selectif du site n-terminal de l'enzyme de conversion de l'angiotensine humaine
PCT/FR1999/001581 WO2000001706A1 (fr) 1998-07-02 1999-07-01 Inhibiteurs selectifs de site n-terminal de l'eca

Publications (1)

Publication Number Publication Date
DK1091966T3 true DK1091966T3 (da) 2003-03-03

Family

ID=9528171

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99926580T DK1091966T3 (da) 1998-07-02 1999-07-01 Selektive inhibitorer af det N-terminale sæde af ACE

Country Status (11)

Country Link
US (1) US6482797B1 (da)
EP (1) EP1091966B1 (da)
JP (1) JP2002519430A (da)
AT (1) ATE227294T1 (da)
CA (1) CA2335918A1 (da)
DE (1) DE69903816T2 (da)
DK (1) DK1091966T3 (da)
ES (1) ES2186366T3 (da)
FR (1) FR2781230B1 (da)
PT (1) PT1091966E (da)
WO (1) WO2000001706A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834989B1 (fr) 2002-01-18 2005-05-20 Commissariat Energie Atomique Derives de pseudo-peptides phosphiniques inhibant selectivement le site actif c-terminal de l'enzyme de conversion de l'angiotensine i(ace)
US20110104175A1 (en) * 2008-06-03 2011-05-05 Cedars-Sinai Medical Center Methods of treatment for pulmonary fibrosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0209848A3 (en) * 1985-07-24 1988-07-27 Merck & Co. Inc. Enzyme inhibitors
FR2676059B1 (fr) * 1991-05-02 1993-07-23 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
FR2730235A1 (fr) * 1995-02-06 1996-08-09 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteur de l'endopeptidase a zinc 24-15
FR2755135B1 (fr) * 1996-10-25 2002-12-27 Inst Nat Sante Rech Med Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
WO2000001706A1 (fr) 2000-01-13
DE69903816D1 (de) 2002-12-12
DE69903816T2 (de) 2003-09-11
ATE227294T1 (de) 2002-11-15
JP2002519430A (ja) 2002-07-02
ES2186366T3 (es) 2003-05-01
FR2781230B1 (fr) 2000-09-01
EP1091966A1 (fr) 2001-04-18
EP1091966B1 (fr) 2002-11-06
US6482797B1 (en) 2002-11-19
CA2335918A1 (fr) 2000-01-13
PT1091966E (pt) 2003-03-31
FR2781230A1 (fr) 2000-01-21

Similar Documents

Publication Publication Date Title
US20050014699A1 (en) Combinations of enzyme inhibitor-containing preparations and the use thereof
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
TW200510306A (en) Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
HUT66512A (en) Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
MY135057A (en) Dolastatin 15 derivatives
FR2861731B1 (fr) Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations
HUP0101899A2 (hu) Cisztein-aktivitástól függő enzimeket gátló hatású tiadiazolvegyületek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
Patterson et al. Substrate specificity and pH dependence of dipeptidases purified from Escherichia coli B and from mouse ascites tumor cells
DK1091966T3 (da) Selektive inhibitorer af det N-terminale sæde af ACE
CA2549185A1 (en) Peptide inhibiting angiotensin converting enzyme
BR0113147A (pt) Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos
PT1095143E (pt) Inibidor para o diagnóstico e tratamento de doentes com hemofilia a
PH12013502021A1 (en) Platelet aggregation inhibitor composition
DK0833848T3 (da) Faktor IX-bindende peptider afledt af faktor VIII og anvendelse heraf som inhibitorer af blodkoagulation
NO20003888L (no) Anti-enzympreparater omfattende etylendiamindiravsyre
ATE299140T1 (de) Farnesyl-protein transferase inhibitoren
Moradian-Oldak et al. Effect of apatite crystals on the activity of amelogenin degrading enzymes in vitro
ATE281522T1 (de) Sentrin-spezifische menschliche protease senp1
ATE230027T1 (de) Menschliche dnase i varianten
DE60301387D1 (en) Phosphinsäure pseudo-peptidderivate
HUP0202653A2 (hu) Autoimmun állapotok kezelése 1-típusú kopolimerrel és rokon kopolimerekkel
HK1023339A1 (en) Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
GEP20033130B (en) Inhibitors of IMPDH Enzyme